Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry
19 nov. 2018 09h01 HE
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, is...
Akers Biosciences Announces Q3 2018 Earnings
15 nov. 2018 07h00 HE
|
Akers Biosciences Inc.
Sales of Flagship PIFA Heparin PF/4 Rapid Assay Products Up 16% over Q3 2017; Company Continuing to Evaluate Strategic Alternatives to Maximize Shareholder Value THOROFARE, N.J., Nov. 15, 2018 ...
Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value
07 nov. 2018 09h15 HE
|
Akers Biosciences Inc
Announces 1:8 Reverse Stock Split THOROFARE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid...